ID BLA5_KLEPN Reviewed; 286 AA. AC P0A3M1; P37320; DT 15-MAR-2005, integrated into UniProtKB/Swiss-Prot. DT 15-MAR-2005, sequence version 1. DT 27-MAR-2024, entry version 67. DE RecName: Full=Beta-lactamase SHV-5; DE EC=3.5.2.6; DE Flags: Precursor; GN Name=bla; Synonyms=shv5; OS Klebsiella pneumoniae. OG Plasmid pAFF1. OC Bacteria; Pseudomonadota; Gammaproteobacteria; Enterobacterales; OC Enterobacteriaceae; Klebsiella/Raoultella group; Klebsiella. OX NCBI_TaxID=573; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC PLASMID=pAFF1; RX PubMed=2088203; DOI=10.1128/aac.34.12.2439; RA Billot-Klein D., Gutmann L., Collatz E.; RT "Nucleotide sequence of the SHV-5 beta-lactamase gene of a Klebsiella RT pneumoniae plasmid."; RL Antimicrob. Agents Chemother. 34:2439-2441(1990). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=KPGE-2, and KPLA-4; RX PubMed=9145849; DOI=10.1128/aac.41.5.943; RA Nuesch-Inderbinen M., Kayser F.H., Hachler H.; RT "Survey and molecular genetics of SHV beta-lactamases in Enterobacteriaceae RT in Switzerland: two novel enzymes, SHV-11 and SHV-12."; RL Antimicrob. Agents Chemother. 41:943-949(1997). CC -!- FUNCTION: SHV enzymes hydrolyze broad spectrum cephalosporins notably CC cefotaxime and ceftazidime. SHV-5 causes particularly high levels of CC resistance to aztreonam and ceftazidime. CC -!- CATALYTIC ACTIVITY: CC Reaction=a beta-lactam + H2O = a substituted beta-amino acid; CC Xref=Rhea:RHEA:20401, ChEBI:CHEBI:15377, ChEBI:CHEBI:35627, CC ChEBI:CHEBI:140347; EC=3.5.2.6; Evidence={ECO:0000255|PROSITE- CC ProRule:PRU10101}; CC -!- SIMILARITY: Belongs to the class-A beta-lactamase family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X55640; CAA39164.1; -; Genomic_DNA. DR EMBL; X98103; CAA66731.1; -; Genomic_DNA. DR EMBL; X98104; CAA66732.1; -; Genomic_DNA. DR PIR; A60632; A60632. DR RefSeq; WP_011117369.1; NZ_WULK01000045.1. DR AlphaFoldDB; P0A3M1; -. DR SMR; P0A3M1; -. DR BindingDB; P0A3M1; -. DR ChEMBL; CHEMBL1075174; -. DR DrugCentral; P0A3M1; -. DR KEGG; ag:CAA39164; -. DR BRENDA; 3.5.2.6; 2814. DR SABIO-RK; P0A3M1; -. DR GO; GO:0008800; F:beta-lactamase activity; IEA:UniProtKB-EC. DR GO; GO:0030655; P:beta-lactam antibiotic catabolic process; IEA:InterPro. DR GO; GO:0046677; P:response to antibiotic; IEA:UniProtKB-KW. DR Gene3D; 3.40.710.10; DD-peptidase/beta-lactamase superfamily; 1. DR InterPro; IPR012338; Beta-lactam/transpept-like. DR InterPro; IPR045155; Beta-lactam_cat. DR InterPro; IPR000871; Beta-lactam_class-A. DR InterPro; IPR023650; Beta-lactam_class-A_AS. DR PANTHER; PTHR35333; BETA-LACTAMASE; 1. DR PANTHER; PTHR35333:SF3; BETA-LACTAMASE2 DOMAIN-CONTAINING PROTEIN; 1. DR Pfam; PF13354; Beta-lactamase2; 1. DR PRINTS; PR00118; BLACTAMASEA. DR SUPFAM; SSF56601; beta-lactamase/transpeptidase-like; 1. DR PROSITE; PS00146; BETA_LACTAMASE_A; 1. PE 3: Inferred from homology; KW Antibiotic resistance; Disulfide bond; Hydrolase; Plasmid; Signal. FT SIGNAL 1..21 FT /evidence="ECO:0000255" FT CHAIN 22..286 FT /note="Beta-lactamase SHV-5" FT /id="PRO_0000016983" FT ACT_SITE 66 FT /note="Acyl-ester intermediate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10101" FT ACT_SITE 164 FT /note="Proton acceptor" FT /evidence="ECO:0000250" FT BINDING 230..232 FT /ligand="substrate" FT /evidence="ECO:0000250" FT DISULFID 73..119 FT /evidence="ECO:0000250" SQ SEQUENCE 286 AA; 31253 MW; 738F426CC51F5FBA CRC64; MRYIRLCIIS LLATLPLAVH ASPQPLEQIK LSESQLSGRV GMIEMDLASG RTLTAWRADE RFPMMSTFKV VLCGAVLARV DAGDEQLERK IHYRQQDLVD YSPVSEKHLA DGMTVGELCA AAITMSDNSA ANLLLATVGG PAGLTAFLRQ IGDNVTRLDR WETELNEALP GDARDTTTPA SMAATLRKLL TSQRLSARSQ RQLLQWMVDD RVAGPLIRSV LPAGWFIADK TGASKRGARG IVALLGPNNK AERIVVIYLR DTPASMAERN QQIAGIGAAL IEHWQR //